Diabetes is on the rise in New Zealand. Hence Pharmac decided to fund for the new once-a-day insulin for those who have serious fluctuations in blood sugar level.
It has decided to give Insulin Glargine or Lantus at a subsidized rate from July 1.
Advertisement
Murray Dear who is the president for the Diabetes New Zealand said that they have worked for obtaining funding to reduce the incidence of diabetes.
He also said that the insulin would not be provided for all the patients who were suffering from Type 1 diabetes.
Lantus would be provided only for those suffering from serious conditions which are life threatening and would be given especially to the young people.
Lantus would be provided only for those suffering from serious conditions which are life threatening and would be given especially to the young people.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
In type 2 diabetes individuals, regular screening for two key cardiac biomarkers may decrease the risk of cardiovascular disease events.
The US Food and Drug Administration (FDA) clears the 'bionic pancreas' that improves the management of type 1 diabetes, without the need for constant blood sugar testing.
A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.
At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.
Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.